New and emerging therapeutic options for thyroid carcinoma: Q&A discussion

摘要

The treatment of differentiated thyroid cancer is evolving. Currently, the only adjuvant treatments for patients at high risk of recurrent disease are external beam radiation therapy and RAJ, and many of these patients are nonavid. New approaches are needed for neoadjuvant treatment and adjuvant treatment with systemic therapy.